Legal Representation
Attorney
Shannon Marie McKeon
USPTO Deadlines
Next Deadline
1142 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-09-13)
Due Date
September 13, 2028
Grace Period Ends
March 13, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 24, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 24, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Jun 24, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 24, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 24, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 24, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 12, 2025 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 13, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Sep 13, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Aug 6, 2022 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Aug 5, 2022 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jul 27, 2022 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Jul 26, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jul 8, 2022 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Jul 8, 2022 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 3, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 27, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 26, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 20, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 19, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 19, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 28, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 28, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 28, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 17, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 24, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 26, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for myeloprotection and anti-tumor effects; pharmaceutical preparations for reducing side effects of chemotherapy; pharmaceutical preparations for use in oncology, improving outcomes from chemotherapy, and treatment of cancer; therapeutic preparations for use in patients with cancer
First Use Anywhere:
20210300
First Use in Commerce:
20210300
Class 042
Pharmaceutical research and development; providing medical and scientific research information in the fields of oncology, pharmaceuticals, therapies, diseases, and disorders
First Use Anywhere:
20200800
First Use in Commerce:
20200800
Additional Information
Pseudo Mark
G ONE THERAPEUTICS
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"